Cellectar Biosciences, Inc. CLRB
1.22 USD +0.07 (+6.09%)
Nov 6, 2026, 12:51 PM EST
1.13 Day range 1.26
1.11 52-week range 4.70
- YTD
- -58.64%
- 1 year
- -64.43%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -22.98M | -51.78M | -38.96M | -28.81M | -24.13M | |
| -21.79M | -44.58M | -42.77M | -31.79M | -24.12M | |
| -8.35 | -41.89 | -105.00 | -135.00 | -131.00 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 13.20M | 23.29M | 9.56M | 19.87M | 35.70M | |
| 14.98M | 25.47M | 12.08M | 21.59M | 37.20M | |
| 5.06M | 9.80M | 25.85M | 12.05M | 4.16M | |
| 409.59K | 494.00K | 552.98K | 603.83K | 301.74K | |
| 8.54M | 14.29M | -15.16M | 8.15M | 33.05M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -23.12M | -47.58M | -32.38M | -25.22M | -22.57M | |
| -5.88K | -104.19K | -864.04K | -225.97K | -141.36K | |
| 13.03M | 61.41M | 22.94M | 9.61M | 1.25M | |
| -5.88K | -104.19K | -864.04K | -225.97K | -141.36K | |
| -10.09M | 13.72M | -10.30M | -15.84M | -21.46M |